Pds biotech chief medical officer, lauren v. wood, to present at the 2021 international head and neck cancer conference

Florham park, n.j., oct. 27, 2021 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the company's proprietary versamune® t-cell activating technology, today announced that the company's chief medical officer, dr. lauren v. wood, will be presenting at the upcoming 2021 international head and neck cancer conference hosted by cardiff, nhs wales and the swallows head & neck cancer support group.
PDSB Ratings Summary
PDSB Quant Ranking